ArticleCancer cell2015

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.

Rebecca M Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.